Skip to content
★ Sign in to follow
CA

China Aoxing Pharmaceutical Company, Inc. Stock: price and insider trades · United States

No insider purchase over the last 90 days. The latest, by Zhang Guoan, was filed 20 Jun 2011.

China Aoxing Pharmaceutical Company, Inc.: what insiders have been doing

China Aoxing Pharmaceutical Company, Inc. is a listed company. Its directors and officers file their transactions with SEC (Form 4). China Aoxing Pharmaceutical Company, Inc. has had no insider filing for more than a year; the last one goes back to 29 April 2015.

The full history, which starts in 2006, counts 7 purchases against no sales.

These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Insider Decl.
37
Thresholds
n/a
Buy Volume
€369,787
7 ops. · all time
Sell Volume
n/a
n/a
Last declaration on 29 April 2015
Declarations37 total
  • ◆
    Chief Financial OfficerExecutives
    136,000 USD0SEC
    100,000 shares@ US$1.36Common StockSEC:0001480097-15-000003:0
  • ◆
    Senior Vice PresidentExecutives
    27,200 USD0SEC
    20,000 shares@ US$1.36Common StockSEC:0001521806-15-000001:0
  • ◆
    Chief Financial OfficerExecutives
    260,000 USD0SEC
    812,500 shares@ US$0.32Common StockSEC:0001480097-15-000002:0
  • ◆
    Vice PresidentExecutives
    324,149 USD0SEC
    831,152 shares@ US$0.39Common StockSEC:0001290929-15-000001:0
  • ◆
    Vice PresidentExecutives
    92,683 USD0SEC
    356,473 shares@ US$0.26Common StockSEC:0001290929-15-000001:1
  • ◆
    Chief Executive OfficerExecutives
    3M USD0SEC
    7,289,199 shares@ US$0.39Common StockSEC:0001290929-15-000002:0
  • ◆
    DirectorExecutives
    7,333 USD0SEC
    19,298 shares@ US$0.38common stockSEC:0001550347-12-000001:0
  • ◆
    DirectorExecutives
    7,333 USD0SEC
    23,656 shares@ US$0.31common stockSEC:0001550347-12-000001:1
  • ◆
    DirectorExecutives
    7,333 USD0SEC
    22,222 shares@ US$0.33common stockSEC:0001550347-12-000001:2
  • ◆
    Chief Financial OfficerExecutives
    4,600 USD0SEC
    20,000 shares@ US$0.23Common StockSEC:0001512563-12-000007:0
  • ◆
    DirectorExecutives
    5,200 USD0SEC
    20,000 shares@ US$0.26Common StockSEC:0001512563-12-000005:0
  • ◆
    DirectorExecutives
    7,334 USD0SEC
    18,804 shares@ US$0.39common stockSEC:0001512563-12-000002:0
  • ◆
    DirectorExecutives
    7,333 USD0SEC
    16,667 shares@ US$0.44common stockSEC:0001512563-12-000002:1
  • ◆
    DirectorExecutives
    7,744 USD0SEC
    18,887 shares@ US$0.41Common StockSEC:0001512563-12-000001:0
  • ◆
    DirectorExecutives
    7,333 USD0SEC
    21,569 shares@ US$0.34Common StockSEC:0001512563-12-000001:1
  • ◆
    DirectorExecutives
    35,272 USD0SEC
    59,783 shares@ US$0.59Common StockSEC:0001512563-11-000002:0
  • ◆
    DirectorExecutives
    8,000 USD0SEC
    20,000 shares@ US$0.40Common StockSEC:0001512563-11-000003:0
  • ●
    Chairman & CEOExecutives
    2M USD0SEC
    802,176 shares@ US$2.70Common StockSEC:0001360531-11-000001:0
  • ◆
    DirectorExecutives
    7,334 USD0SEC
    5,093 shares@ US$1.44Common StockSEC:0001290929-11-000017:0
  • ▲
    Senior VP of FinanceExecutives
    4,601 USD0SEC
    4,300 shares@ US$1.07Common StockSEC:0001521806-11-000002:0
    Canonical exit: 18 Sept 2011 (T+90)
  • ▲
    Senior VP of FinanceExecutives
    44,641 USD0SEC
    47,000 shares@ US$0.9498Common StockSEC:0001521806-11-000001:0
    Canonical exit: 15 Sept 2011 (T+90)
  • ◆
    DirectorExecutives
    36,800 USD0SEC
    20,000 shares@ US$1.84Common StockSEC:0001290929-11-000013:0
  • ◆
    Chairman, C.E.O.Executives
    97,000 USD0SEC
    50,000 shares@ US$1.94COMMON STOCKSEC:0001096906-11-001025:0
  • ◆
    Chairman, C.E.O.Executives
    81,600 USD0SEC
    40,000 shares@ US$2.04COMMON STOCKSEC:0001096906-11-001025:1
  • ◆
    DirectorExecutives
    7,334 USD0SEC
    3,761 shares@ US$1.95Common StockSEC:0001290929-11-000010:0

25 of 37 declarations

About China Aoxing Pharmaceutical Company, Inc.

China Aoxing Pharmaceutical Company, Inc. is a company engaged in the manufacturing and distribution of pharmaceutical products in China. It focuses on the development of traditional Chinese medicines and health products.